• Profile
Close

Elevated plasma sTIM-3 levels in severe COVID-19 patients

The Journal of Allergy and Clinical Immunology Sep 25, 2020

Ueland T, Heggelund L, Lind A, et al. - Researchers analyzed parameters of activation of different leukocyte subsets in relation to disease severity among patients infected with COVID-19. This study involved 39 COVID-19 infected patients. Experts found that there was a link between severe clinical outcome (ICU) and high plasma concentrations soluble T cell immunoglobulin mucin domain-3 (sTIM-3) and myeloperoxidase (MPO) indicating activated and potentially exhausted T cells and activated neutrophils, respectively. They found sCD14 and sCD163 were not related to requirement for ICU treatment. An inverse correlation of sCD25, sTIM-3 and MPO, with the degree of respiratory failure, as evaluated by P/F ratio (arterial partial pressure of oxygen to fraction of inspired oxygen), as well as a positive correlation with the cardiac marker N-terminal pro-B-type natriuretic peptide, was also identified. Overall, experts inferred a likely crucial role of neutrophil activation, and in particular activated T cells, in the pathogenesis of COVID-19 infection. This indicates the possible importance of T cell targeted treatment choices and downregulation of neutrophil activation in this disease.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay